Saving changes...

Done

Error

Antipsychotic Medications in Dementia Care

Antipsychotic Medications in Dementia Care

Antipsychotic Medications in Dementia Care

Carol Knauff
Carol Knauff
on behalf of Pedagogy Incorporated

$10.00 $ 10.00 $ 10.00

$10.00 $ 10.00 $ 10.00

$ 10.00 $ 10.00 $ 10.00
$ 10.00 $ 10.00 $ 10.00
Normal Price: $10.00 $10.00

Review:

Launch date: 18 Sep 2017
Expiry Date:

Last updated: 22 Jan 2018

Reference: 184789

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

Description

Why Antipsychotic Medications are a “no-no”: Providing Excellent Care for Dementia Patients in Long-Term Care Facilities

Have you ever seen a continuing education course’s title and thought that you already knew about that? Maybe it’s the case when dementia or antipsychotic drugs are mentioned. But, have you heard the latest? Are you aware that antipsychotic medication use has been linked to a higher mortality rate in the elderly with dementia? This online continuing education course will provide you insight on several issues related to antipsychotic medication use in the elderly, including its truths and myths, current and future goals of the Centers for Medicare and Medicaid Services (CMS) to improve care within the dementia community and healthcare’s level of knowledge regarding the delivery of dementia care. The debate and struggle over the use of antipsychotic medications will also be discussed. An overview of dementia pathophysiology will be provided as a framework for the background to the information.

Objectives

The objectives of this continuing education course are:
1.Identify the reasons why antipsychotic medications are a hazard when used to control behavioral symptoms in patients with dementia.
2.Discuss non-pharmacologic approaches in an effort to control symptoms.
3.Discuss drugs that are approved by the FDA in dementia.
4.Identify the CMS standards of care by the end of 2015 and by the end of 2016.
5.List CMS recommendations that will discourage antipsychotic medication use.
Carol Knauff

Author Information Play Video Bio

Carol Knauff
on behalf of Pedagogy Incorporated

Carol Knauff holds 35 years of nursing experience in various roles- staff, management, education- with an emphasis in gastrointestinal and critical care specialties. Carol’s passion in nursing is to help nurses understand why they do what they do. Her colleagues find her presentation style unique and look forward to any educational programs that she holds.

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • California Board of Registered Nursing (CBRN)
  • 1.00 Hours
  • Georgia Board of Nursing
  • 1.00 Hours
  • Florida Board of Nursing Home Administrators
  • 1.00 Units -
    Exam Attempts: 3
    -
    Exam Pass Rate: 50

Faculty and Disclosures

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error